Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
7.964M
Cash
41.91M
Avg Qtr Burn
-18.91M
Short % of Float
4.65%
Insider Ownership
28.68%
Institutional Own.
33.83%
Qtr Updated
06/30/24
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
CT-0525 Details Cancer, Solid tumor/s | Phase 1 Data readout | |
CT-0508 (HER2) + pembrolizumab Details Solid tumor/s, Cancer | Phase 1 Update | |
Vicineum™ Details Bladder cancer, Cancer | Failed Discontinued | |
Vicineum™ Details Head and neck squamous cell carcinoma, Cancer | Failed Discontinued | |
CT-0508 (HER2) Details Solid tumor/s, Cancer | Failed Discontinued |